INCYTE CORP

INCY 10-Q · Q3 2025

INCY Q3 2025 request

Playground key active
Request URL /api/financials?ticker=INCY&year=2025&quarter=3
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q3 2025 Q3 2024 YoY
Revenue 1,365,980 1,137,871 +20.0%
Show Product Lines breakouts
ICLUSIG 37,582 29,745 +26.3%
JAKAFI 791,071 741,181 +6.7%
JAKAFI · US 19.3 36.3 -46.8%
JAKAVI Royalty Revenues 125,645 115,741 +8.6%
JAKAVI · Novartis 125.6 115.7 +8.6%
Milestone and contract revenues 45,000 18,000 +150.0%
Milestone and contract revenues · Reportable Segment 45,000 18,000 +150.0%
MINJUVI/MONJUVI 41,990 31,439 +33.6%
NIKTIMVO 45,830
OLUMIANT Royalty Revenues 37,111 34,796 +6.7%
OLUMIANT · Eli Lilly 37.1 34.8 +6.6%
OPZELURA 187,968 139,272 +35.0%
Other product royalty revenues 1,855 414 +348.1%
PEMAZYRE 22,741 20,661 +10.1%
Product 1,149,856 962,992 +19.4%
Product · Reportable Segment 1,149,856 962,992 +19.4%
Royalty 171,124 156,879 +9.1%
Royalty · Reportable Segment 171,124 156,879 +9.1%
TABRECTA Royalty Revenues 6,513 5,928 +9.9%
TABRECTA · Novartis 6.5 5.9 +10.2%
ZYNYZ 22,674 694 +3167.1%
Show Business Segments breakouts
Reportable Segment 1,365,980 1,137,871 +20.0%
Show Geography breakouts
Europe 100,306 66,464 +50.9%
Other countries 4,413 1,367 +222.8%
US 1,261,261 1,070,040 +17.9%
Cost of Revenue 99,001 85,993 +15.1%
Show Business Segments breakouts
Reportable Segment 99,001 85,993 +15.1%
Research & Development 506,584 573,174 -11.6%
Show Type Of Arrangement breakouts
Syndax 6.3 5.8 +8.6%
Selling, General & Administrative 329,081 309,209 +6.4%
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 -12,204 23,410 -152.1%
Show Business Segments breakouts
Reportable Segment -12,204 23,410 -152.1%
Total Costs & Expenses 922,462 991,786 -7.0%
Operating Income 443,518 146,085 +203.6%
Interest Income 26,781 19,266 +39.0%
Interest Expense -592 -774 +23.5%
Equity Securities Fv Ni Gain Loss 8,558 -12,982 +165.9%
Other Non-Operating Income (Expense) 4,043 4,929 -18.0%
Income Before Taxes 482,308 156,524 +208.1%
Income Tax Expense (Benefit) 58,139 50,068 +16.1%
Net Income 424,169 106,456 +298.4%
Show Business Segments breakouts
Reportable Segment 424,169 106,456 +298.4%
Show Equity Components breakouts
Retained Earnings 424,169 106,456 +298.4%
EPS (Basic) 2.17 0.55 +294.5%
EPS (Diluted) 2.11 0.54 +290.7%
Wtd Avg Shares (Basic) 195,670 192,629 +1.6%
Wtd Avg Shares (Diluted) 201,429 195,838 +2.9%
Sales & Marketing (Q)
Show Business Segments breakouts
Reportable Segment 272,302 241,880 +12.6%
General & Administrative (Q)
Show Business Segments breakouts
Reportable Segment 56,779 67,329 -15.7%
Comprehensive Income 425,285 127,531 +233.5%
Other Comprehensive Income 1,116 21,075 -94.7%
Show Equity Components breakouts
Accumulated Other Comprehensive Income 1,116 21,075 -94.7%
Net Income Loss Available To Common Stockholders Basic 424,169 106,456 +298.4%

Balance Sheet

Balance Sheet
Metric Q3 2025 Q3 2024 YoY
Current Assets
Cash & Cash Equivalents 2,455,006 1,304,109 +88.3%
Debt Securities Available For Sale Excluding Accrued Interest Current 474,814
Accounts Receivable Net 895,890 758,450 +18.1%
Inventory 83,447 70,442 +18.5%
Prepaid Expenses & Other Current Assets 368,732 205,128 +79.8%
Total Current Assets 4,277,889 2,808,708 +52.3%
Non-Current Assets
Restricted Cash Noncurrent 1,843 1,737 +6.1%
Equity Securities F V N I Noncurrent 21,870
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level1 · Fair Value Measurements Recurring 21,870
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts
Investment in Syndax 21.9
Show Fair Value By Measurement Basis breakouts
Estimate Of Fair Value Fair Value Disclosure · Fair Value Measurements Recurring 21,870
Inventory Noncurrent 366,510 297,974 +23.0%
Property, Plant & Equipment 798,634
Show Geography breakouts
CH 308,107
Other countries 13,468
US 477,059
Goodwill 155,593 155,593 0.0%
Deferred Tax Assets 528,138 762,310 -30.7%
Other Non-Current Assets 32,303 40,378 -20.0%
Total Assets 6,330,356 5,012,434 +26.3%
Other Assets
Finance Lease Right Of Use Asset 28,155 25,072 +12.3%
Other Intangible Assets Net 119,421 119,994 -0.5%
Current Liabilities
Accounts Payable 171,925 178,710 -3.8%
Employee Related Liabilities Current 168,250 150,722 +11.6%
Accrued Liabilities 948,439 1,127,951 -15.9%
Finance Lease Liability Current 4,491 3,932 +14.2%
Business Combination Contingent Consideration Liability Current 45,624 40,335 +13.1%
Total Current Liabilities 1,338,729 1,501,650 -10.8%
Non-Current Liabilities
Business Combination Contingent Consideration Liability Noncurrent 138,376 166,665 -17.0%
Finance Lease Liability Noncurrent 30,881 28,223 +9.4%
Other Non-Current Liabilities 171,176 144,676 +18.3%
Total Liabilities 1,679,162 1,841,214 -8.8%
Stockholders' Equity
Common Stock 196 192 +2.1%
Additional Paid In Capital Common Stock 4,721,953 4,429,466 +6.6%
Accumulated Other Comprehensive Income 14,555 15,655 -7.0%
Retained Earnings -85,510 -1,274,093 +93.3%
Total Stockholders' Equity 4,651,194 3,171,220 +46.7%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -38,251 -29,655 -29.0%
Accumulated Net Unrealized Investment Gain Loss 1,688 3,314 -49.1%
Accumulated Other Comprehensive Income 14,555 15,655 -7.0%
Accumulated Translation Adjustment 51,118 41,996 +21.7%
Additional Paid In Capital 4,721,953 4,429,466 +6.6%
Common Stock 196 192 +2.1%
Retained Earnings -85,510 -1,274,093 +93.3%
Total Liabilities & Equity 6,330,356 5,012,434 +26.3%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q3 2025 YTD Q3 2024 YoY
Operating Activities
Net Income 987,371 -168,597 +685.6%
Depreciation & Amortization 69,304 66,515 +4.2%
Stock-Based Compensation 187,189 194,340 -3.7%
Increase Decrease In Deferred Income Taxes 234,188 -85,609 +373.6%
Other Non-Cash Items 3,445 -4,824 +171.4%
Change in Accounts Receivable -42,275 -14,893 -183.9%
Change in Prepaid & Other Assets -221,275 -55,381 -299.6%
Change in Inventory -53,654 -93,352 +42.5%
Change in Accounts Payable -26,414 69,109 -138.2%
Increase Decrease In Accrued Liabilities -286,747 149,170 -292.2%
Net Cash from Operations 870,197 -45,881 +1996.6%
Investing Activities
Proceeds From Sale Of Longterm Investments 8 282,866 -100.0%
Payments To Acquire Other Productive Assets -36,990 -68,879 +46.3%
Payments To Acquire Intangible Assets -25,000 -13,900 -79.9%
Payments To Acquire Marketable Securities -212,852 -228,986 +7.0%
Proceeds From Sale And Maturity Of Marketable Securities 209,643 207,881 +0.8%
Net Cash from Investing -65,191 178,982 -136.4%
Financing Activities
Payments For Repurchase Of Common Stock Excise Tax -19,100
Proceeds From Stock Plans 61,553 16,242 +279.0%
Tax Withholding for Share Compensation -60,469 -39,416 -53.4%
Finance Lease Principal Payments -3,386 -2,761 -22.6%
Payment Of Contingent Consideration -15,298 -11,216 -36.4%
Net Cash from Financing -36,700 -2,041,941 +98.2%
Supplemental
Income Taxes Paid 185,221 302,860 -38.8%
Loss Contingency Accrual Payments 294,881
Unpaid Capital Expenditures 4,158 3,538 +17.5%
Right Of Use Asset Obtained In Exchange For Operating Lease Liability 3,163 2,436 +29.8%
Right Of Use Asset Obtained In Exchange For Finance Lease Liability 438 1,959 -77.6%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -908 -535 -69.7%
Net Change in Cash 767,398 -1,909,375 +140.2%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2,456,849 1,305,846 +88.1%

Values in thousands USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key